Nova Eye Medical logo
EYENova Eye Medical
Trade EYE now
Nova Eye Medical primary media

About Nova Eye Medical

Nova Eye Medical (ASX:EYE) is an Australian medical device company focused on the development and commercialisation of novel glaucoma treatment options. The company has a portfolio of proprietary technologies, including its iTrack and Molteno3 glaucoma devices, as well as its 2RT laser therapy for intermediate age-related macular degeneration. Nova Eye's operations are focused on the commercialisation of its existing products and the development of new technologies. The company has a global sales and marketing team in place to support the launch of its iTrack Advance canaloplasty device, which is expected to occur in early 2024.

What is EYE known for?

Snapshot

Public AU
Ownership
1985
Year founded
37
Employees
Adelaide, Australia
Head office
1 of 362
AU Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
Adelaide, AU

Produtos e/ou serviços de Nova Eye Medical

  • iTrack™ Technology: pioneers the iTrack™ microcatheter platform, a minimally invasive system designed to bypass blocked drainage channels and create new pathways for aqueous humour outflow.
  • Molteno3® Family: offers the Molteno3® line of glaucoma drainage implants, tiny stents inserted into the eye to facilitate aqueous humor drainage and pressure reduction.
  • Beyond Traditional Surgery: focuses on minimally invasive and microsurgical approaches, offering earlier intervention and potentially reducing complications compared to traditional glaucoma surgery.
  • Targeting Aqueous Humor Flow: focuses on technologies that manage intraocular pressure through improved drainage and flow control of the aqueous humor, the fluid within the eye.

equipe executiva do Nova Eye Medical

  • Mr. Victor PrevinFounder & Executive Chairman
  • Mr. Thomas H. Spurling AM, BSc (Hons), FRACI, FTSE, Ph.D.MD & Executive Director
  • Ms. Kimberley MenziesChief Financial Officer
  • Mark FlynnInvestor Relations
  • Ms. Kate HuntChief Commercial Officer
  • Mr. Joe BankovichPresident of Global Sales
  • Mr. Joaquin V. WolffPresident of Ellex iTrack
  • Mr. Simon Jeremy Newton Gray BEc, C.A.Company Secretary
  • Jordan PossinghamFinancial Controller
  • Mr. Don WattonVice President of Global Service

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.